Greater Tablet Use at 3.5 Years Tied to More Anger, Frustration at 4.5 years
By Lori Solomon HealthDay Reporter
THURSDAY, Aug. 15, 2024 -- Early-childhood tablet use may contribute to a cycle that is deleterious for emotional regulation, according to a study published online Aug. 12 in JAMA Pediatrics.
Caroline Fitzpatrick, Ph.D., from the Université de Sherbrooke in Québec, Canada, and colleagues estimated how child tablet use contributes to expressions of anger and frustration across the ages of 3.5 to 5.5 years. The analysis included data provided by 315 parents of preschool-aged children.
The researchers found that a 1 standard deviation (SD) increase in tablet use at 3.5 years (1.15 hours per day) was associated with a 22 percent increase in anger/frustration at age 4.5 years. A 1 SD scale increase in anger and frustration at 4.5 years was associated with a 22 percent SD (0.28 hours per day) increase in tablet use at 5.5 years.
"Child ability to effectively downregulate anger and frustration eventually play an important role in the ability to delay gratification and successfully meet the demands of early schooling and future health. Screen use in general and mobile device use in particular are increasingly present in the lives of young children," the authors write. "Our study suggests that parents be sensitized that tablet use in early childhood can disrupt the ability to manage anger and frustration and lead to increased outbursts in young children."
One author disclosed financial ties to Abbott and Libbs.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-16 03:15
Read more
- Two-Fifths of Americans Say They Experience the 'Winter Blues'
- Travel Time to Tanning Facilities Negatively Linked to Melanoma Incidence
- Poor Sleep Quality Linked to Older Brain Age in Late Midlife
- Short-Term Hormone Therapy for Menopause Won't Harm Women's Brains
- Study Assesses Risk for 28-Day Hospitalization for Adults With RSV
- Muvalaplin lowered lipoprotein(a) levels in adults with high risk for cardiovascular events by up to 85% at highest tested dose
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions